Coupang CapEx decreased by 17.8% to $296.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 23.8%, from $239.00M to $296.00M. Over 4 years (FY 2021 to FY 2025), CapEx shows an upward trend with a 16.7% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $168.67M | $190.06M | $168.45M | $238.91M | $180.77M | $283.40M | $120.93M | $95.00M | $377.00M | $190.00M | $234.00M | $107.00M | $178.00M | $380.00M | $214.00M | $239.00M | $299.00M | $353.00M | $360.00M | $296.00M |
| QoQ Change | — | +12.7% | -11.4% | +41.8% | -24.3% | +56.8% | -57.3% | -21.4% | +296.8% | -49.6% | +23.2% | -54.3% | +66.4% | +113.5% | -43.7% | +11.7% | +25.1% | +18.1% | +2.0% | -17.8% |
| YoY Change | — | — | — | — | +7.2% | +49.1% | -28.2% | -60.2% | +108.6% | -33.0% | +93.5% | +12.6% | -52.8% | +100.0% | -8.5% | +123.4% | +68.0% | -7.1% | +68.2% | +23.8% |